Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
1
11%
Ph not_applicable
8
89%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(2)
Terminated(2)
Other(3)

Detailed Status

unknown3
Not yet recruiting2
Completed2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (11.1%)
N/A8 (88.9%)

Trials by Status

terminated111%
unknown333%
withdrawn111%
not_yet_recruiting222%
completed222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9